Search Blog
Categories
December 2018
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Tags

Archive for December 11th, 2018

Mainstream Announces Revocation of Cease Trade Orders and Appointment of Directors

Toronto, Ontario–(Newsfile Corp. – December 11, 2018) – Mainstream Minerals Corporation. (the “Company“) is pleased to announce that it has been successful in its application to the Manitoba Securities Commission, Ontario Securities Commission and British Columbia Securities Commission (collectively, the “Commissions“) to revoke cease trade orders issued by each of the above noted Commissions (the […]

Sphinx clôture un placement privé de 1 million $

By Sphinx Resources Ltd. MONTRÉAL, QC / ACCESSWIRE / le 11 décembre 2018 / Ressources Sphinx ltée (« Sphinx » ou la « Société ») (TSX-V: SFX) annonce qu’elle a réalisé une clôture d’un placement privé sans courtier (le « Placement Privé »), pour un produit brut total de 1 031 000 $. Le Placement […]

Sphinx Closes a $1 Million Private Placement

By Sphinx Resources Ltd. MONTRÉAL, QC / ACCESSWIRE / December 11, 2018 / Sphinx Resources Ltd. (“Sphinx” or the “Corporation”) (TSX- V: SFX) announces it has held a closing of a non-brokered private placement (the “Private Placement”) for aggregate gross proceeds of $1,031,000. The Private Placement was comprised of: 8,100,000 units of the Corporation at […]

ALX Uranium Corp. Announces Application To Amend Warrants Term

Vancouver, British Columbia–(Newsfile Corp. – December 11, 2018) – ALX Uranium Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) (“ALX” or the “Company”) announces that it has made an application to the TSX Venture Exchange (the “TSXV”) to amend the term of an aggregate of 2,410,000 outstanding common share purchase warrants (the “Warrants”), which were issued […]

Vitro Biopharma Receives ISO 9001 Certification

By Vitro Diagnostics/DBA Vitro Biopharma GOLDEN, CO / ACCESSWIRE / December 11, 2018 / Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma (”Vitro”) one of the world’s emerging biotechnology companies focused on Umbilical Cord Mesenchymal Stem Cell (”MSC”) research and clinical products has been awarded Certification to the International Organization for Standardization (ISO) Quality Standard […]

Jupai Holdings Ltd. – Growth Momentum Supported by Product Mix Strategy

By Stone Street Group LLC NEW YORK, NY / ACCESSWIRE / December 11, 2018 / Jupai (NYSE: JP) reported 9M-2018 net revenue of RMB 1,187.4 million (USD $172.9 million), a YoY decrease of 4.7%. Net income attributable to ordinary shareholders was RMB 205.4 million (USD $29.9 million), a YoY decrease of 35.6%, and diluted earnings […]

CIBT Reports Normal Course Issuer Bid

By CIBT Education Group Inc. VANCOUVER, BC / ACCESSWIRE / December 11, 2018 / CIBT Education Group Inc. (TSX: MBA, OTCQX International: MBAIF) (“CIBT Group“) reports that it has received approval from the Toronto Stock Exchange (the “TSX“) to commence a normal course issuer bid (“NCIB“) to purchase up to 2,000,000 of its common shares, […]

American Creek Completes Continuation into British Columbia

Cardston, Alberta–(Newsfile Corp. – December 11, 2018) – American Creek Resources Ltd. (TSXV: AMK) (the “Company”) announces that it has completed its continuance into British Columbia under the British Columbia Business Corporations Act from the federal laws of Canada as of December 11, 2018. The continuance was approved by a special resolution of shareholders at […]

EastWest Announces Change of Directors

By EastWest Bioscience Inc. VANCOUVER, BC / ACCESSWIRE / December 11, 2018 / EastWest Bioscience (formerly Harbour Star Capital Inc.) (the “Company” or “EastWest“) (TSXV: EAST) announces that Mr. Mohammad Fazil has resigned as a director effective as of December 4, 2018, the Company wishes to thank Mr. Fazil for his years of service to […]

Cellerate, LLC Launches Growth Strategy

By WNDM Medical Inc. FORT WORTH, TX / ACCESSWIRE / December 11, 2018 / Cellerate, LLC (”Cellerate”), a company jointly owned by WNDM Medical Inc. (”WNDM”) and an affiliate of The Catalyst Group, Inc. (”Catalyst”) is announcing its growth strategy to expand the distribution of CellerateRX® Activated Collagen® Products as well as its areas of […]